UPDATE: Jefferies Downgrades Apellis Pharmaceuticals (APLS) to Hold
Tweet Send to a Friend
(Updated - November 10, 2022 8:09 AM EST)
Jefferies analyst Chris Howerton downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Chris Howerton downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
